Real-World Outcomes of Trastuzumab Deruxtecan in Patients With Advanced HER2-Positive Breast Cancer With Active Brain Metastasis or Progressive Extracranial Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone
ESMO Open 2023 Oct 20;8(6)102033, J Pearson, A Khan, T Bhogal, H Wong, A Law, S Mills, N Santamaria, J Bishop, J Cliff, D Errington, A Hall, C Hart, Z Malik, R Sripadam, H Innes, H Flint, G Langton, E Ahmed, R Jackson, C PalmieriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.